nodes	percent_of_prediction	percent_of_DWPC	metapath
Desonide—NR3C1—type 2 diabetes mellitus	0.759	1	CbGaD
Desonide—Skin exfoliation—Linagliptin—type 2 diabetes mellitus	0.00291	0.018	CcSEcCtD
Desonide—NR3C1—Endoderm Differentiation—HHEX—type 2 diabetes mellitus	0.00216	0.031	CbGpPWpGaD
Desonide—Upper respiratory tract infection—Linagliptin—type 2 diabetes mellitus	0.00178	0.011	CcSEcCtD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—G6PC—type 2 diabetes mellitus	0.00176	0.0252	CbGpPWpGaD
Desonide—Infestation—Linagliptin—type 2 diabetes mellitus	0.0017	0.0105	CcSEcCtD
Desonide—Infestation NOS—Linagliptin—type 2 diabetes mellitus	0.0017	0.0105	CcSEcCtD
Desonide—Upper respiratory tract infection—Nateglinide—type 2 diabetes mellitus	0.00166	0.0103	CcSEcCtD
Desonide—Viral infection—Gliclazide—type 2 diabetes mellitus	0.00156	0.00966	CcSEcCtD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA6—type 2 diabetes mellitus	0.00156	0.0223	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—INSR—type 2 diabetes mellitus	0.00155	0.0222	CbGpPWpGaD
Desonide—Sweating—Nateglinide—type 2 diabetes mellitus	0.00153	0.00945	CcSEcCtD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF1A—type 2 diabetes mellitus	0.0015	0.0214	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—PDX1—type 2 diabetes mellitus	0.0015	0.0214	CbGpPWpGaD
Desonide—Erythema—Tolbutamide—type 2 diabetes mellitus	0.00148	0.00914	CcSEcCtD
Desonide—Viral infection—Valsartan—type 2 diabetes mellitus	0.00143	0.00887	CcSEcCtD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ABCC8—type 2 diabetes mellitus	0.00143	0.0205	CbGpPWpGaD
Desonide—Blood pressure increased—Gliclazide—type 2 diabetes mellitus	0.00141	0.00872	CcSEcCtD
Desonide—Oedema peripheral—Nateglinide—type 2 diabetes mellitus	0.00141	0.00872	CcSEcCtD
Desonide—Hyperglycaemia—Repaglinide—type 2 diabetes mellitus	0.0014	0.00863	CcSEcCtD
Desonide—Mediastinal disorder—Linagliptin—type 2 diabetes mellitus	0.00138	0.00852	CcSEcCtD
Desonide—Upper respiratory tract infection—Rosiglitazone—type 2 diabetes mellitus	0.00136	0.00841	CcSEcCtD
Desonide—Erythema—Tolazamide—type 2 diabetes mellitus	0.00134	0.00832	CcSEcCtD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—UCP2—type 2 diabetes mellitus	0.00133	0.0191	CbGpPWpGaD
Desonide—Hyperglycaemia—Rosiglitazone—type 2 diabetes mellitus	0.00132	0.00816	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—PHOX2A—type 2 diabetes mellitus	0.00131	0.0187	CbGpPWpGaD
Desonide—Blood pressure increased—Valsartan—type 2 diabetes mellitus	0.0013	0.00801	CcSEcCtD
Desonide—Stinging—Losartan—type 2 diabetes mellitus	0.00129	0.008	CcSEcCtD
Desonide—Erythema—Acarbose—type 2 diabetes mellitus	0.00129	0.00799	CcSEcCtD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—type 2 diabetes mellitus	0.00129	0.0185	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—PCK1—type 2 diabetes mellitus	0.00125	0.0179	CbGpPWpGaD
Desonide—Oedema peripheral—Repaglinide—type 2 diabetes mellitus	0.00122	0.00755	CcSEcCtD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—SLC2A4—type 2 diabetes mellitus	0.00122	0.0175	CbGpPWpGaD
Desonide—Cough—Linagliptin—type 2 diabetes mellitus	0.00116	0.00718	CcSEcCtD
Desonide—Oedema peripheral—Rosiglitazone—type 2 diabetes mellitus	0.00115	0.00713	CcSEcCtD
Desonide—Upper respiratory tract infection—Pioglitazone—type 2 diabetes mellitus	0.00114	0.00705	CcSEcCtD
Desonide—NR3C1—Circadian Clock—NCOA6—type 2 diabetes mellitus	0.00113	0.0162	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—KCNJ11—type 2 diabetes mellitus	0.00113	0.0162	CbGpPWpGaD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Linagliptin—type 2 diabetes mellitus	0.00113	0.00696	CcSEcCtD
Desonide—Blood pressure increased—Irbesartan—type 2 diabetes mellitus	0.00111	0.00689	CcSEcCtD
Desonide—Upper respiratory tract infection—Sitagliptin—type 2 diabetes mellitus	0.00111	0.00685	CcSEcCtD
Desonide—Hyperglycaemia—Pioglitazone—type 2 diabetes mellitus	0.00111	0.00684	CcSEcCtD
Desonide—Sweating—Glipizide—type 2 diabetes mellitus	0.00109	0.00677	CcSEcCtD
Desonide—Infestation—Pioglitazone—type 2 diabetes mellitus	0.00109	0.00676	CcSEcCtD
Desonide—Infestation NOS—Pioglitazone—type 2 diabetes mellitus	0.00109	0.00676	CcSEcCtD
Desonide—Cough—Nateglinide—type 2 diabetes mellitus	0.00109	0.00672	CcSEcCtD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALDOB—type 2 diabetes mellitus	0.00109	0.0156	CbGpPWpGaD
Desonide—Infection—Linagliptin—type 2 diabetes mellitus	0.00108	0.00667	CcSEcCtD
Desonide—Erythema—Repaglinide—type 2 diabetes mellitus	0.00108	0.00667	CcSEcCtD
Desonide—Hyperglycaemia—Sitagliptin—type 2 diabetes mellitus	0.00107	0.00664	CcSEcCtD
Desonide—Infestation—Sitagliptin—type 2 diabetes mellitus	0.00106	0.00657	CcSEcCtD
Desonide—Infestation NOS—Sitagliptin—type 2 diabetes mellitus	0.00106	0.00657	CcSEcCtD
Desonide—Skin disorder—Linagliptin—type 2 diabetes mellitus	0.00106	0.00652	CcSEcCtD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—PPARGC1A—type 2 diabetes mellitus	0.00105	0.015	CbGpPWpGaD
Desonide—Sweating—Pioglitazone—type 2 diabetes mellitus	0.00105	0.00648	CcSEcCtD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—type 2 diabetes mellitus	0.00104	0.0149	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptors—HNF4A—type 2 diabetes mellitus	0.00104	0.0149	CbGpPWpGaD
Desonide—Prednisone—HSD11B1—type 2 diabetes mellitus	0.00104	0.111	CrCbGaD
Desonide—Sweating—Glimepiride—type 2 diabetes mellitus	0.00102	0.00632	CcSEcCtD
Desonide—Pharyngitis—Glipizide—type 2 diabetes mellitus	0.00102	0.00629	CcSEcCtD
Desonide—Skin exfoliation—Losartan—type 2 diabetes mellitus	0.001	0.00619	CcSEcCtD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—F7—type 2 diabetes mellitus	0.000987	0.0141	CbGpPWpGaD
Desonide—Hyperhidrosis—Nateglinide—type 2 diabetes mellitus	0.000983	0.00608	CcSEcCtD
Desonide—Pharyngitis—Pioglitazone—type 2 diabetes mellitus	0.000975	0.00603	CcSEcCtD
Desonide—Oedema peripheral—Pioglitazone—type 2 diabetes mellitus	0.000967	0.00598	CcSEcCtD
Desonide—Pharyngitis—Sitagliptin—type 2 diabetes mellitus	0.000946	0.00585	CcSEcCtD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—SLC2A2—type 2 diabetes mellitus	0.000943	0.0135	CbGpPWpGaD
Desonide—Oedema peripheral—Sitagliptin—type 2 diabetes mellitus	0.000939	0.00581	CcSEcCtD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF4A—type 2 diabetes mellitus	0.000924	0.0132	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—CPT1A—type 2 diabetes mellitus	0.000924	0.0132	CbGpPWpGaD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Repaglinide—type 2 diabetes mellitus	0.000912	0.00564	CcSEcCtD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—GCK—type 2 diabetes mellitus	0.0009	0.0129	CbGpPWpGaD
Desonide—Erythema—Glipizide—type 2 diabetes mellitus	0.000892	0.00552	CcSEcCtD
Desonide—Mediastinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000885	0.00547	CcSEcCtD
Desonide—Asthma—Gliclazide—type 2 diabetes mellitus	0.000885	0.00547	CcSEcCtD
Desonide—NR3C1—Endoderm Differentiation—HNF1B—type 2 diabetes mellitus	0.000861	0.0123	CbGpPWpGaD
Desonide—Mediastinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000859	0.00531	CcSEcCtD
Desonide—Skin disorder—Repaglinide—type 2 diabetes mellitus	0.000855	0.00529	CcSEcCtD
Desonide—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.000854	0.00528	CcSEcCtD
Desonide—Oedema peripheral—Bromocriptine—type 2 diabetes mellitus	0.00085	0.00526	CcSEcCtD
Desonide—Rash—Miglitol—type 2 diabetes mellitus	0.000846	0.00523	CcSEcCtD
Desonide—Dermatitis—Miglitol—type 2 diabetes mellitus	0.000845	0.00523	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—NEUROD1—type 2 diabetes mellitus	0.000843	0.0121	CbGpPWpGaD
Desonide—Mental disorder—Sitagliptin—type 2 diabetes mellitus	0.000835	0.00516	CcSEcCtD
Desonide—Erythema—Glimepiride—type 2 diabetes mellitus	0.000833	0.00515	CcSEcCtD
Desonide—Infection—Rosiglitazone—type 2 diabetes mellitus	0.000826	0.00511	CcSEcCtD
Desonide—Upper respiratory tract infection—Gliclazide—type 2 diabetes mellitus	0.000822	0.00509	CcSEcCtD
Desonide—NR3C1—Nuclear Receptor transcription pathway—HNF4A—type 2 diabetes mellitus	0.000821	0.0118	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—IRS2—type 2 diabetes mellitus	0.000819	0.0117	CbGpPWpGaD
Desonide—Nervous system disorder—Rosiglitazone—type 2 diabetes mellitus	0.000816	0.00504	CcSEcCtD
Desonide—Asthma—Orlistat—type 2 diabetes mellitus	0.000803	0.00497	CcSEcCtD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—LEP—type 2 diabetes mellitus	0.000802	0.0115	CbGpPWpGaD
Desonide—Hyperglycaemia—Gliclazide—type 2 diabetes mellitus	0.000798	0.00494	CcSEcCtD
Desonide—NR3C1—Adipogenesis—RETN—type 2 diabetes mellitus	0.000795	0.0114	CbGpPWpGaD
Desonide—Mediastinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000778	0.00481	CcSEcCtD
Desonide—Pruritus—Tolazamide—type 2 diabetes mellitus	0.000777	0.0048	CcSEcCtD
Desonide—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.000777	0.0048	CcSEcCtD
Desonide—NR3C1—Circadian Clock—CPT1A—type 2 diabetes mellitus	0.000773	0.0111	CbGpPWpGaD
Desonide—Rash—Tolbutamide—type 2 diabetes mellitus	0.000761	0.0047	CcSEcCtD
Desonide—NR3C1—Circadian Clock—NAMPT—type 2 diabetes mellitus	0.000758	0.0109	CbGpPWpGaD
Desonide—Sweating—Gliclazide—type 2 diabetes mellitus	0.000756	0.00468	CcSEcCtD
Desonide—Mental disorder—Bromocriptine—type 2 diabetes mellitus	0.000756	0.00467	CcSEcCtD
Desonide—Headache—Tolbutamide—type 2 diabetes mellitus	0.000756	0.00467	CcSEcCtD
Desonide—Upper respiratory tract infection—Valsartan—type 2 diabetes mellitus	0.000756	0.00467	CcSEcCtD
Desonide—Upper respiratory tract infection—Orlistat—type 2 diabetes mellitus	0.000747	0.00462	CcSEcCtD
Desonide—Infestation NOS—Valsartan—type 2 diabetes mellitus	0.000725	0.00448	CcSEcCtD
Desonide—Infestation—Valsartan—type 2 diabetes mellitus	0.000725	0.00448	CcSEcCtD
Desonide—Cough—Sitagliptin—type 2 diabetes mellitus	0.000724	0.00448	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Pioglitazone—type 2 diabetes mellitus	0.000723	0.00447	CcSEcCtD
Desonide—NR3C1—Nuclear Receptors—AR—type 2 diabetes mellitus	0.00072	0.0103	CbGpPWpGaD
Desonide—Pruritus—Nateglinide—type 2 diabetes mellitus	0.000719	0.00445	CcSEcCtD
Desonide—NR3C1—Circadian Clock—F7—type 2 diabetes mellitus	0.000719	0.0103	CbGpPWpGaD
Desonide—Infestation NOS—Orlistat—type 2 diabetes mellitus	0.000716	0.00443	CcSEcCtD
Desonide—Infestation—Orlistat—type 2 diabetes mellitus	0.000716	0.00443	CcSEcCtD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—IRS1—type 2 diabetes mellitus	0.000715	0.0102	CbGpPWpGaD
Desonide—Hyperhidrosis—Glipizide—type 2 diabetes mellitus	0.000704	0.00435	CcSEcCtD
Desonide—Pharyngitis—Gliclazide—type 2 diabetes mellitus	0.000703	0.00435	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Sitagliptin—type 2 diabetes mellitus	0.000702	0.00434	CcSEcCtD
Desonide—Asthma—Irbesartan—type 2 diabetes mellitus	0.000699	0.00432	CcSEcCtD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—type 2 diabetes mellitus	0.000699	0.01	CbGpPWpGaD
Desonide—Oedema peripheral—Gliclazide—type 2 diabetes mellitus	0.000698	0.00431	CcSEcCtD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—type 2 diabetes mellitus	0.000693	0.00993	CbGpPWpGaD
Desonide—Infection—Pioglitazone—type 2 diabetes mellitus	0.000693	0.00429	CcSEcCtD
Desonide—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000692	0.00428	CcSEcCtD
Desonide—Rash—Tolazamide—type 2 diabetes mellitus	0.000692	0.00428	CcSEcCtD
Desonide—Upper respiratory tract infection—Metformin—type 2 diabetes mellitus	0.000688	0.00425	CcSEcCtD
Desonide—Headache—Tolazamide—type 2 diabetes mellitus	0.000688	0.00425	CcSEcCtD
Desonide—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000688	0.00425	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—KCNQ1—type 2 diabetes mellitus	0.000687	0.00984	CbGpPWpGaD
Desonide—Erythema—Glyburide—type 2 diabetes mellitus	0.000687	0.00425	CcSEcCtD
Desonide—Rash—Linagliptin—type 2 diabetes mellitus	0.000685	0.00423	CcSEcCtD
Desonide—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000684	0.00423	CcSEcCtD
Desonide—Nervous system disorder—Pioglitazone—type 2 diabetes mellitus	0.000684	0.00423	CcSEcCtD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—type 2 diabetes mellitus	0.000684	0.00979	CbGpPWpGaD
Desonide—Headache—Linagliptin—type 2 diabetes mellitus	0.000681	0.00421	CcSEcCtD
Desonide—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.000678	0.00419	CcSEcCtD
Desonide—NR3C1—Circadian Clock—SREBF1—type 2 diabetes mellitus	0.000676	0.00968	CbGpPWpGaD
Desonide—Hyperhidrosis—Pioglitazone—type 2 diabetes mellitus	0.000674	0.00417	CcSEcCtD
Desonide—Infection—Sitagliptin—type 2 diabetes mellitus	0.000673	0.00416	CcSEcCtD
Desonide—Rash—Acarbose—type 2 diabetes mellitus	0.000665	0.00411	CcSEcCtD
Desonide—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.000664	0.00411	CcSEcCtD
Desonide—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000664	0.00411	CcSEcCtD
Desonide—Infestation—Metformin—type 2 diabetes mellitus	0.00066	0.00408	CcSEcCtD
Desonide—Infestation NOS—Metformin—type 2 diabetes mellitus	0.00066	0.00408	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—ATF3—type 2 diabetes mellitus	0.00066	0.00945	CbGpPWpGaD
Desonide—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.000658	0.00407	CcSEcCtD
Desonide—Hyperhidrosis—Glimepiride—type 2 diabetes mellitus	0.000657	0.00406	CcSEcCtD
Desonide—Upper respiratory tract infection—Irbesartan—type 2 diabetes mellitus	0.000649	0.00402	CcSEcCtD
Desonide—Pharyngitis—Valsartan—type 2 diabetes mellitus	0.000646	0.00399	CcSEcCtD
Desonide—Rash—Nateglinide—type 2 diabetes mellitus	0.000641	0.00396	CcSEcCtD
Desonide—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000641	0.00396	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—ECE1—type 2 diabetes mellitus	0.000639	0.00915	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—G6PC—type 2 diabetes mellitus	0.000639	0.00915	CbGpPWpGaD
Desonide—Pharyngitis—Orlistat—type 2 diabetes mellitus	0.000638	0.00395	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.000635	0.00393	CcSEcCtD
Desonide—Oedema peripheral—Orlistat—type 2 diabetes mellitus	0.000633	0.00392	CcSEcCtD
Desonide—Hyperglycaemia—Irbesartan—type 2 diabetes mellitus	0.00063	0.0039	CcSEcCtD
Desonide—NR3C1—Adipogenesis—HNF1A—type 2 diabetes mellitus	0.000629	0.009	CbGpPWpGaD
Desonide—Pain—Glipizide—type 2 diabetes mellitus	0.000623	0.00385	CcSEcCtD
Desonide—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000623	0.00385	CcSEcCtD
Desonide—Mental disorder—Gliclazide—type 2 diabetes mellitus	0.000621	0.00384	CcSEcCtD
Desonide—Erythema—Gliclazide—type 2 diabetes mellitus	0.000617	0.00381	CcSEcCtD
Desonide—Upper respiratory tract infection—Losartan—type 2 diabetes mellitus	0.000611	0.00378	CcSEcCtD
Desonide—Infection—Bromocriptine—type 2 diabetes mellitus	0.000609	0.00377	CcSEcCtD
Desonide—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000601	0.00372	CcSEcCtD
Desonide—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000595	0.00368	CcSEcCtD
Desonide—Hyperglycaemia—Losartan—type 2 diabetes mellitus	0.000593	0.00367	CcSEcCtD
Desonide—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000589	0.00364	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—type 2 diabetes mellitus	0.000587	0.00841	CbGpPWpGaD
Desonide—Mediastinal disorder—Valsartan—type 2 diabetes mellitus	0.000586	0.00363	CcSEcCtD
Desonide—Oedema peripheral—Metformin—type 2 diabetes mellitus	0.000584	0.00361	CcSEcCtD
Desonide—NR3C1—Adipogenesis—MIF—type 2 diabetes mellitus	0.00058	0.00831	CbGpPWpGaD
Desonide—Mediastinal disorder—Orlistat—type 2 diabetes mellitus	0.00058	0.00358	CcSEcCtD
Desonide—Pain—Sitagliptin—type 2 diabetes mellitus	0.000579	0.00358	CcSEcCtD
Desonide—Mental disorder—Valsartan—type 2 diabetes mellitus	0.00057	0.00353	CcSEcCtD
Desonide—NR3C1—Nuclear Receptor transcription pathway—AR—type 2 diabetes mellitus	0.000569	0.00815	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HNF4A—type 2 diabetes mellitus	0.000567	0.00812	CbGpPWpGaD
Desonide—Asthma—Ramipril—type 2 diabetes mellitus	0.000564	0.00349	CcSEcCtD
Desonide—Mental disorder—Orlistat—type 2 diabetes mellitus	0.000563	0.00348	CcSEcCtD
Desonide—Sweating—Losartan—type 2 diabetes mellitus	0.000562	0.00348	CcSEcCtD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—type 2 diabetes mellitus	0.000558	0.00798	CbGpPWpGaD
Desonide—Pharyngitis—Irbesartan—type 2 diabetes mellitus	0.000555	0.00343	CcSEcCtD
Desonide—Rash—Repaglinide—type 2 diabetes mellitus	0.000555	0.00343	CcSEcCtD
Desonide—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000554	0.00343	CcSEcCtD
Desonide—NR3C1—Regulation of Androgen receptor activity—AR—type 2 diabetes mellitus	0.000552	0.0079	CbGpPWpGaD
Desonide—Headache—Repaglinide—type 2 diabetes mellitus	0.000551	0.00341	CcSEcCtD
Desonide—Oedema peripheral—Irbesartan—type 2 diabetes mellitus	0.000551	0.00341	CcSEcCtD
Desonide—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.00055	0.0034	CcSEcCtD
Desonide—NR3C1—Nuclear Receptors—PPARA—type 2 diabetes mellitus	0.000546	0.00782	CbGpPWpGaD
Desonide—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000542	0.00335	CcSEcCtD
Desonide—Cough—Gliclazide—type 2 diabetes mellitus	0.000538	0.00333	CcSEcCtD
Desonide—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000534	0.0033	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—TIMP1—type 2 diabetes mellitus	0.000528	0.00756	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—PCK1—type 2 diabetes mellitus	0.000527	0.00754	CbGpPWpGaD
Desonide—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000524	0.00324	CcSEcCtD
Desonide—Upper respiratory tract infection—Ramipril—type 2 diabetes mellitus	0.000524	0.00324	CcSEcCtD
Desonide—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000524	0.00324	CcSEcCtD
Desonide—Pharyngitis—Losartan—type 2 diabetes mellitus	0.000522	0.00323	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000521	0.00322	CcSEcCtD
Desonide—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000521	0.00322	CcSEcCtD
Desonide—Erythema—Metformin—type 2 diabetes mellitus	0.000516	0.00319	CcSEcCtD
Desonide—Pruritus—Glipizide—type 2 diabetes mellitus	0.000515	0.00319	CcSEcCtD
Desonide—NR3C1—Circadian Clock—PPARGC1A—type 2 diabetes mellitus	0.000505	0.00723	CbGpPWpGaD
Desonide—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000504	0.00312	CcSEcCtD
Desonide—NR3C1—Regulation of Androgen receptor activity—SIRT1—type 2 diabetes mellitus	0.000503	0.00721	CbGpPWpGaD
Desonide—Infection—Gliclazide—type 2 diabetes mellitus	0.0005	0.00309	CcSEcCtD
Desonide—NR3C1—Circadian Clock—AVP—type 2 diabetes mellitus	0.000498	0.00713	CbGpPWpGaD
Desonide—Cough—Valsartan—type 2 diabetes mellitus	0.000494	0.00306	CcSEcCtD
Desonide—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000493	0.00305	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—TCF7L2—type 2 diabetes mellitus	0.000491	0.00704	CbGpPWpGaD
Desonide—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000489	0.00302	CcSEcCtD
Desonide—Cough—Orlistat—type 2 diabetes mellitus	0.000488	0.00302	CcSEcCtD
Desonide—Erythema—Irbesartan—type 2 diabetes mellitus	0.000487	0.00301	CcSEcCtD
Desonide—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000486	0.00301	CcSEcCtD
Desonide—Sweating—Ramipril—type 2 diabetes mellitus	0.000482	0.00298	CcSEcCtD
Desonide—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000481	0.00297	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000479	0.00296	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000473	0.00293	CcSEcCtD
Desonide—Infection—Valsartan—type 2 diabetes mellitus	0.000459	0.00284	CcSEcCtD
Desonide—Rash—Glipizide—type 2 diabetes mellitus	0.000459	0.00284	CcSEcCtD
Desonide—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000459	0.00284	CcSEcCtD
Desonide—Erythema—Losartan—type 2 diabetes mellitus	0.000458	0.00283	CcSEcCtD
Desonide—Headache—Glipizide—type 2 diabetes mellitus	0.000456	0.00282	CcSEcCtD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—type 2 diabetes mellitus	0.000455	0.00652	CbGpPWpGaD
Desonide—Infection—Orlistat—type 2 diabetes mellitus	0.000454	0.00281	CcSEcCtD
Desonide—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000453	0.0028	CcSEcCtD
Desonide—NR3C1—Nuclear Receptors—PPARG—type 2 diabetes mellitus	0.000451	0.00646	CbGpPWpGaD
Desonide—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000449	0.00278	CcSEcCtD
Desonide—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000448	0.00277	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—GJA1—type 2 diabetes mellitus	0.000445	0.00638	CbGpPWpGaD
Desonide—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000445	0.00275	CcSEcCtD
Desonide—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000444	0.00274	CcSEcCtD
Desonide—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000442	0.00273	CcSEcCtD
Desonide—Headache—Pioglitazone—type 2 diabetes mellitus	0.000437	0.0027	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000436	0.0027	CcSEcCtD
Desonide—NR3C1—Nuclear Receptor transcription pathway—PPARA—type 2 diabetes mellitus	0.000431	0.00618	CbGpPWpGaD
Desonide—Pain—Gliclazide—type 2 diabetes mellitus	0.00043	0.00266	CcSEcCtD
Desonide—Rash—Glimepiride—type 2 diabetes mellitus	0.000428	0.00265	CcSEcCtD
Desonide—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000428	0.00265	CcSEcCtD
Desonide—Rash—Sitagliptin—type 2 diabetes mellitus	0.000427	0.00264	CcSEcCtD
Desonide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000427	0.00264	CcSEcCtD
Desonide—Headache—Glimepiride—type 2 diabetes mellitus	0.000426	0.00263	CcSEcCtD
Desonide—Cough—Irbesartan—type 2 diabetes mellitus	0.000425	0.00263	CcSEcCtD
Desonide—Headache—Sitagliptin—type 2 diabetes mellitus	0.000424	0.00262	CcSEcCtD
Desonide—Infection—Metformin—type 2 diabetes mellitus	0.000418	0.00259	CcSEcCtD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—type 2 diabetes mellitus	0.000415	0.00595	CbGpPWpGaD
Desonide—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000413	0.00255	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000412	0.00255	CcSEcCtD
Desonide—Skin disorder—Metformin—type 2 diabetes mellitus	0.000409	0.00253	CcSEcCtD
Desonide—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000407	0.00252	CcSEcCtD
Desonide—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000407	0.00251	CcSEcCtD
Desonide—NR3C1—Circadian Clock—PPARA—type 2 diabetes mellitus	0.000406	0.00581	CbGpPWpGaD
Desonide—Cough—Losartan—type 2 diabetes mellitus	0.0004	0.00247	CcSEcCtD
Desonide—Pruritus—Glyburide—type 2 diabetes mellitus	0.000396	0.00245	CcSEcCtD
Desonide—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000395	0.00244	CcSEcCtD
Desonide—Infection—Irbesartan—type 2 diabetes mellitus	0.000395	0.00244	CcSEcCtD
Desonide—NR3C1—Circadian Clock—HIF1A—type 2 diabetes mellitus	0.000395	0.00565	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—type 2 diabetes mellitus	0.000393	0.00563	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—type 2 diabetes mellitus	0.000393	0.00563	CbGpPWpGaD
Desonide—Erythema—Ramipril—type 2 diabetes mellitus	0.000393	0.00243	CcSEcCtD
Desonide—Pain—Orlistat—type 2 diabetes mellitus	0.000391	0.00242	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—EDN1—type 2 diabetes mellitus	0.000391	0.00559	CbGpPWpGaD
Desonide—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.00039	0.00241	CcSEcCtD
Desonide—Rash—Bromocriptine—type 2 diabetes mellitus	0.000387	0.00239	CcSEcCtD
Desonide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000386	0.00239	CcSEcCtD
Desonide—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000386	0.00239	CcSEcCtD
Desonide—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000384	0.00237	CcSEcCtD
Desonide—Headache—Bromocriptine—type 2 diabetes mellitus	0.000384	0.00237	CcSEcCtD
Desonide—NR3C1—Adipogenesis—NAMPT—type 2 diabetes mellitus	0.000381	0.00545	CbGpPWpGaD
Desonide—Infection—Losartan—type 2 diabetes mellitus	0.000371	0.0023	CcSEcCtD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—type 2 diabetes mellitus	0.000371	0.00531	CbGpPWpGaD
Desonide—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000367	0.00227	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—type 2 diabetes mellitus	0.000362	0.00519	CbGpPWpGaD
Desonide—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000361	0.00224	CcSEcCtD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—type 2 diabetes mellitus	0.000361	0.00517	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—type 2 diabetes mellitus	0.000356	0.00511	CbGpPWpGaD
Desonide—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000356	0.0022	CcSEcCtD
Desonide—Rash—Glyburide—type 2 diabetes mellitus	0.000353	0.00218	CcSEcCtD
Desonide—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000353	0.00218	CcSEcCtD
Desonide—Headache—Glyburide—type 2 diabetes mellitus	0.000351	0.00217	CcSEcCtD
Desonide—NR3C1—Adipogenesis—HMGA1—type 2 diabetes mellitus	0.000346	0.00496	CbGpPWpGaD
Desonide—Cough—Ramipril—type 2 diabetes mellitus	0.000343	0.00212	CcSEcCtD
Desonide—Pain—Irbesartan—type 2 diabetes mellitus	0.00034	0.0021	CcSEcCtD
Desonide—NR3C1—Adipogenesis—SREBF1—type 2 diabetes mellitus	0.000339	0.00486	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.000336	0.00481	CbGpPWpGaD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000332	0.00205	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—MMP1—type 2 diabetes mellitus	0.000328	0.0047	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.000327	0.00468	CbGpPWpGaD
Desonide—Pruritus—Valsartan—type 2 diabetes mellitus	0.000327	0.00202	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—HIF1A—type 2 diabetes mellitus	0.000325	0.00466	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—AGT—type 2 diabetes mellitus	0.000324	0.00464	CbGpPWpGaD
Desonide—Pruritus—Orlistat—type 2 diabetes mellitus	0.000323	0.002	CcSEcCtD
Desonide—Pain—Losartan—type 2 diabetes mellitus	0.00032	0.00198	CcSEcCtD
Desonide—Rash—Gliclazide—type 2 diabetes mellitus	0.000317	0.00196	CcSEcCtD
Desonide—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000317	0.00196	CcSEcCtD
Desonide—Headache—Gliclazide—type 2 diabetes mellitus	0.000315	0.00195	CcSEcCtD
Desonide—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000314	0.00194	CcSEcCtD
Desonide—NR3C1—Adipogenesis—ADIPOQ—type 2 diabetes mellitus	0.000312	0.00446	CbGpPWpGaD
Desonide—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000311	0.00193	CcSEcCtD
Desonide—Prednicarbate—NR3C1—type 2 diabetes mellitus	0.00031	0.0333	CrCbGaD
Desonide—Clocortolone—NR3C1—type 2 diabetes mellitus	0.00031	0.0333	CrCbGaD
Desonide—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.00031	0.00192	CcSEcCtD
Desonide—NR3C1—Circadian Clock—SERPINE1—type 2 diabetes mellitus	0.000302	0.00433	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—type 2 diabetes mellitus	0.000299	0.00429	CbGpPWpGaD
Desonide—Pruritus—Metformin—type 2 diabetes mellitus	0.000298	0.00184	CcSEcCtD
Desonide—NR3C1—Adipogenesis—SLC2A4—type 2 diabetes mellitus	0.000294	0.00422	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.000293	0.0042	CbGpPWpGaD
Desonide—Diflorasone—NR3C1—type 2 diabetes mellitus	0.000293	0.0315	CrCbGaD
Desonide—Rash—Valsartan—type 2 diabetes mellitus	0.000292	0.0018	CcSEcCtD
Desonide—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000291	0.0018	CcSEcCtD
Desonide—Headache—Valsartan—type 2 diabetes mellitus	0.00029	0.00179	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—type 2 diabetes mellitus	0.000289	0.00414	CbGpPWpGaD
Desonide—Rash—Orlistat—type 2 diabetes mellitus	0.000288	0.00178	CcSEcCtD
Desonide—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000288	0.00178	CcSEcCtD
Desonide—Headache—Orlistat—type 2 diabetes mellitus	0.000286	0.00177	CcSEcCtD
Desonide—Desoximetasone—NR3C1—type 2 diabetes mellitus	0.000286	0.0307	CrCbGaD
Desonide—Loteprednol—NR3C1—type 2 diabetes mellitus	0.000283	0.0303	CrCbGaD
Desonide—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000281	0.00174	CcSEcCtD
Desonide—Fludrocortisone—AR—type 2 diabetes mellitus	0.000279	0.0299	CrCbGaD
Desonide—NR3C1—AP-1 transcription factor network—CCL2—type 2 diabetes mellitus	0.000267	0.00382	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—IGF2BP2—type 2 diabetes mellitus	0.000266	0.00381	CbGpPWpGaD
Desonide—Rash—Metformin—type 2 diabetes mellitus	0.000265	0.00164	CcSEcCtD
Desonide—Dermatitis—Metformin—type 2 diabetes mellitus	0.000265	0.00164	CcSEcCtD
Desonide—Pruritus—Losartan—type 2 diabetes mellitus	0.000265	0.00164	CcSEcCtD
Desonide—Headache—Metformin—type 2 diabetes mellitus	0.000264	0.00163	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—type 2 diabetes mellitus	0.000263	0.00377	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—PPARGC1A—type 2 diabetes mellitus	0.000254	0.00363	CbGpPWpGaD
Desonide—Rash—Irbesartan—type 2 diabetes mellitus	0.000251	0.00155	CcSEcCtD
Desonide—Flurandrenolide—NR3C1—type 2 diabetes mellitus	0.00025	0.0269	CrCbGaD
Desonide—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00025	0.00155	CcSEcCtD
Desonide—Headache—Irbesartan—type 2 diabetes mellitus	0.000249	0.00154	CcSEcCtD
Desonide—Hydrocortamate—NR3C1—type 2 diabetes mellitus	0.000242	0.026	CrCbGaD
Desonide—Rash—Losartan—type 2 diabetes mellitus	0.000236	0.00146	CcSEcCtD
Desonide—Dermatitis—Losartan—type 2 diabetes mellitus	0.000236	0.00146	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.000235	0.00336	CbGpPWpGaD
Desonide—Headache—Losartan—type 2 diabetes mellitus	0.000234	0.00145	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—CDKN2A—type 2 diabetes mellitus	0.000233	0.00333	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.000233	0.00333	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—LPL—type 2 diabetes mellitus	0.000231	0.00331	CbGpPWpGaD
Desonide—Pruritus—Ramipril—type 2 diabetes mellitus	0.000227	0.0014	CcSEcCtD
Desonide—Amcinonide—NR3C1—type 2 diabetes mellitus	0.000225	0.0242	CrCbGaD
Desonide—Budesonide—NR3C1—type 2 diabetes mellitus	0.000225	0.0242	CrCbGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—type 2 diabetes mellitus	0.000222	0.00318	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—SRC—type 2 diabetes mellitus	0.00022	0.00315	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.000219	0.00314	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.000219	0.00314	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	0.000216	0.0031	CbGpPWpGaD
Desonide—Mometasone—NR3C1—type 2 diabetes mellitus	0.000214	0.023	CrCbGaD
Desonide—Rimexolone—NR3C1—type 2 diabetes mellitus	0.000212	0.0227	CrCbGaD
Desonide—NR3C1—Adipogenesis—FAS—type 2 diabetes mellitus	0.000211	0.00302	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—NCOA6—type 2 diabetes mellitus	0.000208	0.00298	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—PPARA—type 2 diabetes mellitus	0.000204	0.00292	CbGpPWpGaD
Desonide—Rash—Ramipril—type 2 diabetes mellitus	0.000202	0.00125	CcSEcCtD
Desonide—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000202	0.00125	CcSEcCtD
Desonide—Headache—Ramipril—type 2 diabetes mellitus	0.000201	0.00124	CcSEcCtD
Desonide—Beclomethasone—NR3C1—type 2 diabetes mellitus	0.0002	0.0214	CrCbGaD
Desonide—Fluocinonide—NR3C1—type 2 diabetes mellitus	0.0002	0.0214	CrCbGaD
Desonide—NR3C1—Adipogenesis—HIF1A—type 2 diabetes mellitus	0.000198	0.00284	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—IRS2—type 2 diabetes mellitus	0.000198	0.00283	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—AGT—type 2 diabetes mellitus	0.000198	0.00283	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—RELA—type 2 diabetes mellitus	0.000197	0.00283	CbGpPWpGaD
Desonide—Fluocinolone Acetonide—NR3C1—type 2 diabetes mellitus	0.000194	0.0208	CrCbGaD
Desonide—Alclometasone—NR3C1—type 2 diabetes mellitus	0.000194	0.0208	CrCbGaD
Desonide—NR3C1—Adipogenesis—LEP—type 2 diabetes mellitus	0.000194	0.00277	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—MMP9—type 2 diabetes mellitus	0.000191	0.00273	CbGpPWpGaD
Desonide—Clobetasol propionate—NR3C1—type 2 diabetes mellitus	0.000189	0.0203	CrCbGaD
Desonide—Fludrocortisone—NR3C1—type 2 diabetes mellitus	0.000189	0.0203	CrCbGaD
Desonide—Flunisolide—NR3C1—type 2 diabetes mellitus	0.000189	0.0203	CrCbGaD
Desonide—Paramethasone—NR3C1—type 2 diabetes mellitus	0.000187	0.02	CrCbGaD
Desonide—Ciclesonide—NR3C1—type 2 diabetes mellitus	0.000184	0.0197	CrCbGaD
Desonide—Fluorometholone—NR3C1—type 2 diabetes mellitus	0.000182	0.0196	CrCbGaD
Desonide—Methylprednisolone—NR3C1—type 2 diabetes mellitus	0.000176	0.0189	CrCbGaD
Desonide—NR3C1—Adipogenesis—IRS1—type 2 diabetes mellitus	0.000173	0.00247	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000171	0.00245	CbGpPWpGaD
Desonide—Dexamethasone—CYP11A1—type 2 diabetes mellitus	0.000169	0.0181	CrCbGaD
Desonide—NR3C1—Adipogenesis—PPARG—type 2 diabetes mellitus	0.000169	0.00242	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—type 2 diabetes mellitus	0.000166	0.00238	CbGpPWpGaD
Desonide—Clobetasol propionate—CYP1A2—type 2 diabetes mellitus	0.000165	0.0178	CrCbGaD
Desonide—NR3C1—Adipogenesis—INS—type 2 diabetes mellitus	0.000165	0.00237	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—TGFB1—type 2 diabetes mellitus	0.000161	0.00231	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—IGF1—type 2 diabetes mellitus	0.00016	0.00229	CbGpPWpGaD
Desonide—Hydrocortisone—SHBG—type 2 diabetes mellitus	0.00016	0.0171	CrCbGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—type 2 diabetes mellitus	0.000159	0.00227	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—TGFB1—type 2 diabetes mellitus	0.000157	0.00225	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—SERPINE1—type 2 diabetes mellitus	0.000152	0.00218	CbGpPWpGaD
Desonide—Triamcinolone—NR3C1—type 2 diabetes mellitus	0.000148	0.0159	CrCbGaD
Desonide—NR3C1—Generic Transcription Pathway—HNF4A—type 2 diabetes mellitus	0.000142	0.00203	CbGpPWpGaD
Desonide—Hydrocortamate—CYP3A4—type 2 diabetes mellitus	0.00014	0.0151	CrCbGaD
Desonide—Dexamethasone—NOS2—type 2 diabetes mellitus	0.00014	0.015	CrCbGaD
Desonide—Prednisone—NR3C1—type 2 diabetes mellitus	0.000135	0.0145	CrCbGaD
Desonide—Budesonide—CYP3A4—type 2 diabetes mellitus	0.000131	0.014	CrCbGaD
Desonide—Prednisolone—NR3C1—type 2 diabetes mellitus	0.000124	0.0133	CrCbGaD
Desonide—NR3C1—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	0.000122	0.00174	CbGpPWpGaD
Desonide—Betamethasone—NR3C1—type 2 diabetes mellitus	0.000122	0.0131	CrCbGaD
Desonide—NR3C1—AP-1 transcription factor network—IL6—type 2 diabetes mellitus	0.000119	0.0017	CbGpPWpGaD
Desonide—Alclometasone—CYP3A4—type 2 diabetes mellitus	0.000113	0.0121	CrCbGaD
Desonide—Flunisolide—CYP3A4—type 2 diabetes mellitus	0.00011	0.0118	CrCbGaD
Desonide—Paramethasone—CYP3A4—type 2 diabetes mellitus	0.000108	0.0116	CrCbGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	0.000106	0.00152	CbGpPWpGaD
Desonide—Ciclesonide—CYP3A4—type 2 diabetes mellitus	0.000106	0.0114	CrCbGaD
Desonide—Fluorometholone—CYP3A4—type 2 diabetes mellitus	0.000106	0.0113	CrCbGaD
Desonide—NR3C1—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	0.000105	0.00151	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—type 2 diabetes mellitus	0.000104	0.0015	CbGpPWpGaD
Desonide—Methylprednisolone—CYP3A4—type 2 diabetes mellitus	0.000102	0.011	CrCbGaD
Desonide—NR3C1—Gene Expression—NCOA6—type 2 diabetes mellitus	0.0001	0.00143	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	9.95e-05	0.00143	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—AR—type 2 diabetes mellitus	9.83e-05	0.00141	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	9.73e-05	0.00139	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—type 2 diabetes mellitus	9.64e-05	0.00138	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—TGFB1—type 2 diabetes mellitus	9.59e-05	0.00137	CbGpPWpGaD
Desonide—Hydrocortisone—NR3C1—type 2 diabetes mellitus	9.49e-05	0.0102	CrCbGaD
Desonide—Dexamethasone—ABCC2—type 2 diabetes mellitus	9.28e-05	0.00996	CrCbGaD
Desonide—NR3C1—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	9.06e-05	0.0013	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	9.03e-05	0.00129	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—TNF—type 2 diabetes mellitus	8.96e-05	0.00128	CbGpPWpGaD
Desonide—Triamcinolone—CYP3A4—type 2 diabetes mellitus	8.61e-05	0.00924	CrCbGaD
Desonide—Triamcinolone—PTGS2—type 2 diabetes mellitus	8.43e-05	0.00905	CrCbGaD
Desonide—Prednisone—CYP3A4—type 2 diabetes mellitus	7.81e-05	0.00838	CrCbGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	7.74e-05	0.00111	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	7.45e-05	0.00107	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—IL6—type 2 diabetes mellitus	7.23e-05	0.00103	CbGpPWpGaD
Desonide—Prednisolone—CYP3A4—type 2 diabetes mellitus	7.2e-05	0.00773	CrCbGaD
Desonide—Dexamethasone—NR3C1—type 2 diabetes mellitus	7.07e-05	0.0076	CrCbGaD
Desonide—Betamethasone—CYP3A4—type 2 diabetes mellitus	7.05e-05	0.00757	CrCbGaD
Desonide—Betamethasone—PTGS2—type 2 diabetes mellitus	6.9e-05	0.00741	CrCbGaD
Desonide—NR3C1—Gene Expression—HNF4A—type 2 diabetes mellitus	6.83e-05	0.000978	CbGpPWpGaD
Desonide—Prednisone—ALB—type 2 diabetes mellitus	6.81e-05	0.00731	CrCbGaD
Desonide—Dexamethasone—CYP2E1—type 2 diabetes mellitus	6.51e-05	0.00699	CrCbGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	6.25e-05	0.000895	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	6.16e-05	0.000882	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—PSMD6—type 2 diabetes mellitus	5.97e-05	0.000855	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—DNMT1—type 2 diabetes mellitus	5.97e-05	0.000855	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—CTGF—type 2 diabetes mellitus	5.86e-05	0.000839	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	5.55e-05	0.000794	CbGpPWpGaD
Desonide—Hydrocortisone—CYP3A4—type 2 diabetes mellitus	5.5e-05	0.00591	CrCbGaD
Desonide—NR3C1—Gene Expression—NOTCH2—type 2 diabetes mellitus	5.07e-05	0.000727	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—AR—type 2 diabetes mellitus	4.73e-05	0.000678	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—CDKN2B—type 2 diabetes mellitus	4.36e-05	0.000625	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—SIRT1—type 2 diabetes mellitus	4.31e-05	0.000618	CbGpPWpGaD
Desonide—Dexamethasone—CYP3A4—type 2 diabetes mellitus	4.1e-05	0.0044	CrCbGaD
Desonide—Dexamethasone—PTGS2—type 2 diabetes mellitus	4.02e-05	0.00431	CrCbGaD
Desonide—NR3C1—Gene Expression—PPP2CA—type 2 diabetes mellitus	3.81e-05	0.000546	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—PPARA—type 2 diabetes mellitus	3.59e-05	0.000514	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—PPARG—type 2 diabetes mellitus	2.96e-05	0.000425	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—SERPINE1—type 2 diabetes mellitus	2.67e-05	0.000382	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—AKT1—type 2 diabetes mellitus	1.17e-05	0.000168	CbGpPWpGaD
